MicroRNA-let-7a promotes E2F-mediated cell proliferation and NFκB activation in vitro

Cellular and Molecular Immunology

Volumn 11, Issue 1, 2014, Pages 79-93

  Chafin, Cristen B ^a,d   Regna, Nicole L ^a   Caudell, David L ^b   Reilly, Christopher M ^a,c  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c EDWARD VIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^d CENTER FOR MOLECULAR MEDICINE AND INFECTIOUS DISEASES   (United States)

Author keywords

Cell proliferation; E2F; MicroRNA let 7a; NF B; Systemic lupus erythematosus

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MESSENGER RNA; MICRORNA; MICRORNA LET 7A; PROTEIN ANTIBODY; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F2; TRANSCRIPTION FACTOR E2F5; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; BIOINFORMATICS; CELL COUNT; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL STIMULATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA SEQUENCE; DOWN REGULATION; GENE CONTROL; GENE OVEREXPRESSION; HYPERPLASIA; IN VITRO STUDY; MACROPHAGE; MESANGIUM CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN RNA BINDING; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSCRIPTION REGULATION; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; E2F2 TRANSCRIPTION FACTOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOPRECIPITATION; INTERLEUKIN-6; MACROPHAGES; MESANGIAL CELLS; MICE; MICRORNAS; NF-KAPPA B; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN TRANSPORT; REAL-TIME POLYMERASE CHAIN REACTION; RETINOBLASTOMA PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 84891769619     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2013.51     Document Type: Article

References (76)

1. Kashem A, Endoh M, Yano N, Yamauchi F, Nomoto Y, Sakai H. Expression of inducible-NOS in human glomerulonephritis: the possible source is infiltrating monocytes/macrophages. Kidney Int 1996; 50: 392-399.
2. de Zubiria Salgado A, Herrera-Diaz C. Lupus nephritis: an overview of recent findings. Autoimmune Dis 2012; 2012: 849684.
3. Seret G, Le Meur Y, Renaudineau Y, Youinou P. Mesangial cellspecific antibodies are central to the pathogenesis of lupus nephritis. Clin Dev Immunol 2012; 2012: 579670.
4. Li Y, Lee PY, Reeves WH. Monocyte and macrophage abnormalities in systemic lupus erythematosus. Arch Immunol Ther Exp 2010; 58: 355-364.
5. Pathak S, Mohan C. Cellular and molecular pathogenesis of systemic lupus erythematosus: lessons from animal models. Arthritis Res Ther 2011; 13: 241.
6. Choi J, Kim ST, Craft J. The pathogenesis of systemic lupus erythematosus-an update. Curr Opin Immunol 2012; 24: 651-657.
7. Granholm NA, Cavallo T. Mechanism of localization of immune complexes in NZB/W mice with early nephritis. Autoimmunity 1990; 8: 17-24.
8. Menè P. Physiology and pathophysiology of the mesangial cell. Nefrologia 1996; 16: 8-13.
9. Lewis EJ, Schwartz MM. Pathology of lupus nephritis. Lupus 2005; 14: 31-38.
10. Naugler WE, Karin M. NF-kappaB and cancer-identifying targets and mechanisms. Curr Opin Genet Dev 2008; 18: 19-26.
11. Hayden MS, Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008; 132: 344-362.
12. Gupta SC, Kim JH, Kannappan R, Reuter S, Dougherty PM, Aggarwal BB. Role of nuclear factor kappaB-mediated inflammatory pathways in cancer-related symptoms and their regulation by nutritional agents. Exp Biol Med (Maywood) 2011; 236: 658-671.
13. Iliopoulos D, Hirsch HA, Struhl K. An epigenetic switch involving NFkappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 2009; 139: 693-706.
14. Yap DY, Lai KN. Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advances. J Biomed Biotechnol 2010; 2010: 365083.
15. Ranieri E, Gesualdo L, Petrarulo F, Schena FP. Urinary IL-6/EGF ratio: a useful prognostic marker for the progression of renal damage in IgA nephropathy. Kidney Int 1996; 50: 1990-2001.
16. Tackey E, Lipsky PE, Illei GG. Rationale for interleukin-6 blockade in systemic lupus erythematosus. Lupus 2004; 13: 339-343.
17. Eitner F, Westerhuis R, Burg M, Weinhold B, Grone HJ, Ostendorf T et al. Role of interleukin-6 in mediating mesangial cell proliferation and matrix production in vivo. Kidney Int 1997; 51: 69-78.
18. Peairs A, Dai R, Gan L, Shimp S, Rylander MN, Li L et al. Epigallocatechin-3-gallate (EGCG) attenuates inflammation in MRL/lpr mouse mesangial cells. Cell Mol Immunol 2010; 7: 123-132.
19. Cove-Smith A, Hendry BM. The regulation of mesangial cell proliferation. Nephron Exp Nephrol 2008; 108: e74-e79.
20. Kong EK, Chong WP, Wong WH, Lau CS, Chan TM, Ng PK et al. p21 gene polymorphisms in systemic lupus erythematosus. Rheumatology (Oxford) 2007; 46: 220-226.
21. Liu ZC, Zhou QL. Tumor necrosis factor-like weak inducer of apoptosis and its potential roles in lupus nephritis. Inflamm Res 2012; 61: 277-284.
22. Attwooll C, Lazzerini Denchi E, Helin K. The E2F family: specific functions and overlapping interests. EMBOJ 2004; 23: 4709-4716.
23. Stevaux O, Dyson NJ. A revised picture of the E2F transcriptional network and RB function. Curr Opin Cell Biol 2002; 14: 684-691.
24. Poznic M. Retinoblastoma protein: a central processing unit. J Biosci 2009; 34: 305-312.
25. Armananzas R, Calvo B, Inza I, Lopez-Hoyos M, Martinez-Taboada V, Ucar E et al. Microarray analysis of autoimmune diseases by machine learning procedures. IEEE Trans Inf Technol Biomed 2009; 13: 341-350.
26. Renaudineau Y, Youinou P. Epigenetics and autoimmunity, with special emphasis on methylation. Keio J Med 2011; 60: 10-16.
27. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5: 522-531.
28. Bazzoni F, Rossato M, Fabbri M, Gaudiosi D, Mirolo M, Mori L et al. Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Proc Natl Acad Sci USA 2009; 106: 5282-5287.
29. Wanet A, Tacheny A, Arnould T, Renard P. miR-212/132 expression and functions: within and beyond the neuronal compartment. Nucleic Acids Res 2012; 40: 4742-4753.
30. Liu G, Friggeri A, Yang Y, Park YJ, Tsuruta Y, Abraham E. miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses. Proc Natl Acad Sci USA 2009; 106: 15819-15824.
31. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kappaBdependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006; 103: 12481-12486.
32. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci USA 2007; 104: 1604-1609.
33. Chafin CB, Regna NL, Dai R, Caudell DL, Reilly CM. MicroRNA-let-7a expression is increased in the mesangial cells of NZB/W mice and increases IL-6 production in vitro. Autoimmunity 2013; 46: 351-362.
34. Ma F, Liu X, Li D, Wang P, Li N, Lu L et al. MicroRNA-466l upregulates IL-10 expression in TLR-triggered macrophages by antagonizing RNA-binding protein tristetraprolin-mediated IL-10 mRNA degradation. J Immunol 2010; 184: 6053-6059.
35. Asirvatham AJ, Magner WJ, Tomasi TB. miRNA regulation of cytokine genes. Cytokine 2009; 45: 58-69.
36. Dai Y, Sui W, Lan H, Yan Q, Huang H, Huang Y. Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol Int. 2009; 29: 749-754.
37. de Vito C, Riggi N, Suva ML, Janiszewska M, Horlbeck J, Baumer K et al. Let-7a is a direct EWS-FLI-1 target implicated in Ewing's sarcoma development. PLoS ONE 2011; 6: e23592.
38. Izzotti A. Molecular medicine and the development of cancer chemopreventive agents. Ann NY Acad Sci 2012; 1259: 26-32.
39. Bueno MJ, Gomez de Cedron M, Laresgoiti U, Fernandez-Piqueras J, Zubiaga AM, Malumbres M. Multiple E2F-induced microRNAs prevent replicative stress in response to mitogenic signaling. Mol Cell Biol 2010; 30: 2983-2995.
40. Liu Y, Yin B, Zhang C, Zhou L, Fan J. Hsa-let-7a functions as a tumor suppressor in renal cell carcinoma cell lines by targeting c-myc. Biochem Biophys Res Commun 2012; 417: 371-375.
41. Wang YY, Ren T, Cai YY, He XY. MicroRNA let-7a inhibits the proliferation and invasion of nonsmall cell lung cancer cell line 95D by regulating K-Ras and HMGA2 gene expression. Cancer Biother Radiopharm 2013; 28: 131-137.
42. Dong Q, Meng P, Wang T, Qin W, Wang F, Yuan J et al. MicroRNA let-7a inhibits proliferation of human prostate cancer cells in vitro and in vivo by targeting E2F2 and CCND2. PLoS ONE 2010; 5: e10147.
43. Ormerod MG. Flow Cytometry: A Practical Approach. 3rd ed. New York: Oxford University Press, Inc., 2000.
44. Dai R, Phillips RA, Zhang Y, Khan D, Crasta O, Ahmed SA. Suppression of LPS-induced interferon-gamma and nitric oxide in splenic lymphocytes by select estrogen-regulated microRNAs: a novel mechanism of immune modulation. Blood 2008; 112: 4591-4597.
45. Messeguer X, Escudero R, Farre D, Nunez O, Martinez J, Alba MM. PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics 2002; 18: 333-334.
46. Farre D, Roset R, Huerta M, Adsuara JE, Rosello L, Alba MM et al. Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN. Nucleic Acids Res 2003; 31: 3651-3653.
47. Welch PJ, Wang JY. A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Cell 1993; 75: 779-790.
48. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995; 81: 323-330.
49. Urashima M, Ogata A, Chauhan D, Vidriales MB, Teoh G, Hoshi Y et al. Interleukin-6 promotes multiple myeloma cell growth via phosphorylation of retinoblastoma protein. Blood 1996; 88: 2219-2227.
50. Wang DJ, Legesse-Miller A, Johnson EL, Coller HA. Regulation of the let-7a-3 promoter by NF-kappaB. PLoS ONE 2012; 7: e31240.
51. Shimp SK 3rd, Parson CD, Regna NL, Thomas AN, Chafin CB, Reilly CM et al. HSP90 inhibition by 17-DMAG reduces inflammation in J774 macrophages through suppression of Akt and nuclear factorkappaB pathways. Inflamm Res 2012; 61: 521-533.
52. Son YH, Jeong YT, Lee KA, Choi KH, Kim SM, Rhim BY et al. Roles of MAPK and NF-kappaB in interleukin-6 induction by lipopolysaccharide in vascular smooth muscle cells. J. Cardiovasc Pharmacol 2008; 51: 71-77.
53. Libermann TA, Baltimore D. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol 1990; 10: 2327-2334.
54. Kuzmanova SI. The macrophage activation syndrome: a new entity, a potentially fatal complication of rheumatic disorders. Folia Med (Plovdiv) 2005; 47: 21-25.
55. Grammer AC, Lipsky PE. B cell abnormalities in systemic lupus erythematosus. Arthritis Res Ther 2003;5(Suppl 4): S22-S27.
56. Scheinecker C, Bonelli M, Smolen JS. Pathogenetic aspects of systemic lupus erythematosus with an emphasis on regulatory T cells. J Autoimmun 2010; 35: 269-275.
57. Yung S, Chan TM. Autoantibodies and resident renal cells in the pathogenesis of lupus nephritis: getting to know the unknown. Clin Dev Immunol 2012; 2012: 139365.
58. Aran AA, Putterman C. Treatment of lupus nephritis: facing the era of immunotherapy. Panminerva Med 2008; 50: 235-245.
59. Ramanujam M, Davidson A. Targeting of the immune system in systemic lupus erythematosus. Expert Rev Mol Med 2008; 10: e2.
60. Michaud-Levesque J, Bousquet-Gagnon N, Beliveau R. Quercetin abrogates IL-6/STAT3 signaling and inhibits glioblastoma cell line growth and migration. Exp Cell Res 2012; 318: 925-935.
61. Henley SA, Dick FA. The retinoblastoma family of proteins and their regulatory functions in the mammalian cell division cycle. Cell Div 2012; 7: 10.
62. Yang Q, Jie Z, Cao H, Greenlee AR, Yang C, Zou F et al. Low-level expression of let-7a in gastric cancer and its involvement in tumorigenesis by targeting RAB40C. Carcinogenesis 2011; 32: 713-722.
63. Zhu Y, Zhong Z, Liu Z. Lentiviral vector-mediated upregulation of let-7a inhibits gastric carcinoma cell growth in vitro and in vivo. Scand J Gastroenterol 2011; 46: 53-59.
64. Jakymiw A, Patel RS, Deming N, Bhattacharyya I, Shah P, Lamont RJ et al. Overexpression of dicer as a result of reduced let-7 MicroRNA levels contributes to increased cell proliferation of oral cancer cells. Genes Chromosomes Cancer 2010; 49: 549-559.
65. Khodayari N, Mohammed KA, Goldberg EP, Nasreen N. EphrinA1 inhibits malignant mesothelioma tumor growth via let-7 microRNA mediated repression of the RAS oncogene. Cancer Gene Ther 2011; 18: 806-816.
66. Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science 2007; 318: 1931-1934.
67. Grande JP. Mechanisms of progression of renal damage in lupus nephritis: pathogenesis of renal scarring. Lupus 1998; 7: 604-610.
68. Alonso MM, Alemany R, Fueyo J, Gomez-Manzano C. E2F1 in gliomas: a paradigm of oncogene addiction. Cancer Lett 2008; 263: 157-163.
69. Johnson DG, Degregori J. Putting the oncogenic and tumor suppressive activities of E2F into context. Curr Mol Med 2006; 6: 731-738.
70. Schocklmann HO, Lang S, Sterzel RB. Regulation of mesangial cell proliferation. Kidney Int 1999; 56: 1199-1207.
71. Tomita N, Horiuchi M, Tomita S, Gibbons GH, Kim JY, Baran D et al. An oligonucleotide decoy for transcription factor E2F inhibits mesangial cell proliferation in vitro. Am J Physiol 1998; 275: F278-F284.
72. Maeshima Y, Kashihara N, Yasuda T, Sugiyama H, Sekikawa T, Okamoto K et al. Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo. J Clin Invest 1998; 101: 2589-2597.
73. Celhar T, Magalhaes R, Fairhurst AM. TLR7 and TLR9 in SLE: when sensing self goes wrong. Immunol Res 2012; 53: 58-77.
74. Kulkarni O, Anders HJ. Chemokines in lupus nephritis. Front Biosci 2008; 13: 3312-3320.
75. Theofilopoulos AN, Kono DH, Beutler B, Baccala R. Intracellular nucleic acid sensors and autoimmunity. J Interferon Cytokine Res 2011; 31: 867-886.
76. Liang B, Gardner DB, Griswold DE, Bugelski PJ, Song XY. Antiinterleukin-6. monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus. Immunology 2006; 119: 296-305.